Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

46.11
+0.71001.56%
Post-market: 46.110.00000.00%19:30 EDT
Volume:1.19M
Turnover:54.73M
Market Cap:7.74B
PE:118.77
High:46.11
Open:44.98
Low:44.75
Close:45.40
52wk High:55.67
52wk Low:26.40
Shares:167.76M
Float Shares:155.00M
Volume Ratio:0.93
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3882
EPS(LYR):1.43
ROE:3.85%
ROA:4.20%
PB:4.28
PE(LYR):32.24

Loading ...

Alkermes Announces Launch of 9TH Annual Alkermes Pathways Research Awards® Program

THOMSON REUTERS
·
Yesterday

Mizuho survey shows no consensus into Alkermes ADHD data

TIPRANKS
·
Sep 05

Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34

Reuters
·
Sep 04

Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874

Reuters
·
Sep 02

Alkermes’ Alixorexton Posts Positive Phase 2 Vibrance-1 Results in Narcolepsy Type 1 Study

Reuters
·
Aug 25

The Lancet Neurology Publishes Data from Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults with Narcolepsy Type 1

THOMSON REUTERS
·
Aug 25

Alkermes SVP, Chief Commercial Officer Christian Todd Nichols Sells 7,576 Shares for $374,301.99

Reuters
·
Aug 18

Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment

Reuters
·
Aug 12

Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 12

Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing

THOMSON REUTERS
·
Aug 12

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72

Reuters
·
Aug 04

Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award

Reuters
·
Aug 04

Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says

MT Newswires Live
·
Jul 29

Alkermes Plc : Jefferies Raises Target Price to $72 from $65

THOMSON REUTERS
·
Jul 29

Alkermes Plc : TD Cowen Raises Target Price to $58 from $57

THOMSON REUTERS
·
Jul 29

Alkermes Plc : Baird Raises Target Price to $58 from $48

THOMSON REUTERS
·
Jul 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 29

Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler

Dow Jones
·
Jul 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)

TIPRANKS
·
Jul 28